AS Registry
D
David Streitman, MD
Primary Investigator
Enrolling By Invitation
2 years or below
All
Phase
N/A
10 participants needed
1 Location
Brief description of study
Objectives: To 1) determine performance characteristics of ultrasound (US), magnetic resonance imaging (MRI) and genetic testing (GT) in the prenatal diagnosis of aqueductal stenosis; 2) determine the gestational age that the diagnosis can be accurately made, and 3) to determine pediatric outcomes at 2 years in a contemporarily managed cohort of children with AS.
Detailed description of study
The main outcomes of
interest are the performance characteristics of prenatal imaging using
postnatal neuroimaging as the gold standard, and the gestational age that the
diagnosis can be made. This information
will be used to assess our ability to accurately identify a patient population
who may benefit from in-utero intervention i.e. those with isolated AS. Additionally,
newborns with AS will be followed for two years to assess neurologic outcomes
after conventional management.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: aqueductal stenosis, Riley
-
Age: 2 years or below
-
Gender: All
Inclusion Criteria:
- Fetus with aqueductal stenosis
Exclusion Criteria:
Updated on
14 Sep 2024.
Study ID: 17575; PNEO-NAFTN-AS-REGISTRY
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
